Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41598-017-15583-3

http://scihub22266oqcxt.onion/10.1038/s41598-017-15583-3
suck pdf from google scholar
C5680268!5680268 !29123197
unlimited free pdf from europmc29123197
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29123197 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid29123197
      Sci+Rep 2017 ; 7 (1 ): 15233
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments #MMPMID29123197
  • Ando Y ; Ta HP ; Yen DP ; Lee SS ; Raola S ; Shen K
  • Sci Rep 2017[Nov]; 7 (1 ): 15233 PMID29123197 show ga
  • Hypoxia plays a central role in cancer progression and resistance to therapy. We have engineered a microdevice platform to recapitulate the intratumor oxygen gradients that drive the heterogeneous hypoxic landscapes in solid tumors. Our design features a "tumor section"-like culture by incorporating a cell layer between two diffusion barriers, where an oxygen gradient is established by cellular metabolism and physical constraints. We confirmed the oxygen gradient by numerical simulation and imaging-based oxygen sensor measurement. We also demonstrated spatially-resolved hypoxic signaling in cancer cells through immunostaining, gene expression assay, and hypoxia-targeted drug treatment. Our platform can accurately generate and control oxygen gradients, eliminates complex microfluidic handling, allows for incorporation of additional tumor components, and is compatible with high-content imaging and high-throughput applications. It is well suited for understanding hypoxia-mediated mechanisms in cancer disease and other biological processes, and discovery of new therapeutics.
  • |*Hypoxia [MESH]
  • |*Tumor Microenvironment [MESH]
  • |Cytological Techniques/*instrumentation/*methods [MESH]
  • |Gene Expression Profiling [MESH]
  • |Humans [MESH]
  • |Immunohistochemistry [MESH]
  • |MCF-7 Cells [MESH]
  • |Neoplasms/*pathology [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box